The deep in-the-money warrants are almost certain to be exercised, triggering significant share issuance. Traders should anticipate sharp downward pressure on INM stock as dilution hits the market. Monitor for Form 3 filings and subsequent 8-Ks reporting exercise notices.
Price Chart
Executive Summary
InMed Pharmaceuticals amended preferred investment options (warrants) held by Sabby and H.C. Wainwright affiliates, reducing the exercise price from as high as $82.50 down to $0.80 per share. This makes the warrants deeply in-the-money relative to the current stock price (implied by the $2M market cap), enabling the holders to immediately purchase up to 2,304,714 common shares – more than doubling the outstanding shares and severely diluting existing shareholders.
Key Financial Metrics
Key Facts
- Sabby warrants amended to exercise price of $0.80 (was $2.436); Sabby can buy up to 2,151,478 shares.
- Wainwright warrants amended to exercise price of $0.80 (were as high as $82.50); Wainwright can buy up to 153,236 shares.
- Total potential new shares: 2,304,714 (excluding any other adjustments).
- Company market cap is $2M; the amendments enable massive dilution relative to current float.
- No financial figures (revenue, EPS) were provided in the filing.
Financial Impact
Potential proceeds up to $1.84M from warrant exercise, but at extreme dilution cost – shares could more than double outstanding count.
Risk Factors
- Massive shareholder dilution from warrant exercise.
- Potential decline in stock price as supply of shares increases.
- No mention of use of proceeds; cash raised likely insufficient to offset dilutive impact.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001213900-26-048064 |
| Document: ea028772801ex10-2.htm | 0001213900-26-048064 |
| Document: ea028772801ex99-1.htm | 0001213900-26-048064 |
| Document: ea028772801ex10-1.htm | 0001213900-26-048064 |
| Document: 0001213900-26-048064-index-headers.html | 0001213900-26-048064 |
| Document: 0001213900-26-048064-index.html | 0001213900-26-048064 |
| Document: 0001213900-26-048064.txt | 0001213900-26-048064 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 9, 2026 23d ago | 425 | $1.31 $1.39 | ▲ +6.11% | ▲ +6.61% | $1.33 (+1.53%) |
Jul 10, 2026 12w ago | 8-K | $1.57 $1.52 | ▲ +3.18% | ▲ +2.40% | $1.33 (+15.29%) |
Jul 2, 2026 13w ago | S-4 | $1.56 $1.66 | ▼ −6.41% | ▼ −5.48% | $1.33 (+14.74%) |
Jun 11, 2026 16w ago | Insider Cluster | $1.58 $1.49 | ▼ −5.70% | ▼ −6.13% | $1.33 (−15.82%) |
Jun 10, 2026 16w ago | 8-K | $1.51 $1.48 | ▼ −1.99% | ▼ −5.42% | $1.33 (−11.92%) |
May 19, 2026 19w ago | 425 | $1.60 $1.69 | ▲ +5.63% | ▲ +3.38% | $1.33 (−16.87%) |
May 19, 2026 19w ago | 8-K | $1.60 $1.69 | ▲ +5.63% | ▲ +3.38% | $1.33 (−16.87%) |
May 19, 2026 19w ago | 8-K | $1.60 $1.66 | ▼ −3.75% | ▼ −1.45% | $1.33 (+16.87%) |
Apr 27, 2026 22w ago | 8-K | $0.7010 $0.7480 | ▼ −6.70% | ▼ −5.01% | $1.33 (−89.73%) |
Apr 3, 2026 26w ago | 8-K | $0.6950 $0.7130 | ▲ +2.59% | ▼ −1.54% | $1.33 (+91.37%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access